Showing results (951-960 of 962) with videos related to
Sort By:
Pageof 97
European Heart Journal|September 27, 2021
Macrophage NFATc3 prevents foam cell formation and atherosclerosis: evidence and mechanismsXiu Liu, Jia-Wei Guo, Xiao-Chun Lin, et al.Innovation (Cambridge (Mass.))|February 21, 2024
GTF2H4 regulates partial EndMT via NF-κB activation through NCOA3 phosphorylation in ischemic diseasesZheyan Fang, Gang Zhao, Shuang Zhao, et al.International Journal of Biological Sciences|May 10, 2024
HMGA1 sensitizes esophageal squamous cell carcinoma to mTOR inhibitors through the ETS1-FKBP12 axisJin-Rong Guo, Kai-Yue He, Jia-Li Yuan, et al.Infectious Diseases of Poverty|June 30, 2021
Feasibility of controlling hepatitis E in Jiangsu Province, China: a modelling studyMeng Yang, Xiao-Qing Cheng, Ze-Yu Zhao, et al.Oncotarget|July 1, 2015
Long-term results of a randomized phase III trial of TPF induction chemotherapy followed by surgery and radiation in locally advanced oral squamous cell carcinomaLai-ping Zhong, Chen-ping Zhang, Guo-xin Ren, et al.Global Change Biology|September 28, 2019
Global vegetation biomass production efficiency constrained by models and observationsYue He, Shushi Peng, Yongwen Liu, et al.Cryobiology|July 13, 2025
Expert consensus on cryosurgery therapy of mucosal melanoma on head and neckYadong Wu, Guoxin Ren, Moyi Sun, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 7, 2012
Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinomaLai-ping Zhong, Chen-ping Zhang, Guo-xin Ren, et al.Biorxiv : the Preprint Server for Biology|September 15, 2025
Reprogramming Factors Activate a Non-Canonical Oxidative Resilience Pathway That Can Rejuvenate RPEs and Restore VisionYuancheng Ryan Lu, James C Cameron, Yan Hu, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 14, 2025
SIRT6 Lysine-Demyristoylates ATF2 to Ameliorate Vascular Injury via PRKCD/VE-Cadherin Pathway Regulating Vascular Endothelial BarrierRunyang Feng, Zheyan Fang, Shuang Zhao, et al.Pageof 97